Injectable, Battery‑Free Device Offers New Hope for Chronic Pain

Imagine a device no larger than a sesame seed slipping into your body through a regular needle, then quietly nudging a nerve to calm pain. That’s the promise of a new bioelectronic interface created by researchers at NYU Abu Dhabi in partnership with the Cleveland Clinic Abu Dhabi.

The tiny gadget, about the size of a small seed, is implanted next to a target nerve and receives power from an external transmitter – no battery, no wires, no scalpels. Once positioned, it can emit carefully shaped electrical pulses that either quiet overactive signals or boost weak ones, depending on what the patient needs.

What makes this approach feel almost futuristic is its simplicity. Doctors can guide the injection with routine imaging tools like ultrasound or CT, watch the device settle where it’s supposed to be, and later tweak the stimulation settings from outside the body. In other words, the whole therapy can be adjusted in real time without another operation.

Early laboratory work and pre‑clinical trials in animals showed the device can reliably fire the right kind of pulse and stay functional under conditions that mimic everyday movement. The researchers even demonstrated that it can activate a living nerve in vivo, a crucial step toward real‑world use.

"We’re shifting the paradigm from permanent, surgically implanted hardware to something you can inject and then control remotely," says Prof. Khalil Ramadi, senior author of the study published in "Science Advances". "It keeps the precision doctors need while cutting down on the risks and recovery time patients face."

While the results are encouraging, the team cautions that human trials are still needed to prove safety and effectiveness for chronic‑pain sufferers or people with movement disorders. If those studies pan out, this technology could lessen the reliance on opioid medications and make advanced neuromodulation accessible to a broader population.

Beyond pain, the platform could be adapted for a range of nerve‑related conditions, from spasticity after stroke to tremors in Parkinson’s disease. The collaboration highlights how multidisciplinary teams—engineers, clinicians, and imaging specialists—can accelerate breakthroughs that feel almost like science‑fiction becoming reality.